Item 5. Market for Registrant’s Common Equity
Item
5
Market For Registrant’s Common Equity, Related Stockholder
Matters And Issuer Purchases Of Equity Securities.
Market
Information
Shares
of our common stock trade in the pink sheets market and quotations for the common stock are listed in the “Pink Sheets” produced
by the OTC Markets under the symbol “HGYN”.
The
following table sets forth for the respective periods indicated the prices of our common stock in this market as reported and summarized
by the National Quotation Bureau. Such prices are based on inter-dealer bid and asked prices, without markup, markdown, commissions,
or adjustments and may not represent actual transactions.
Year ended December 31, 2020
High
Low
First Quarter
$ .001
$ .0003
Second Quarter
.0015
.001
Third Quarter
.002
.0003
Fourth Quarter
.002
.0003
Year ended December 31, 2021
High
Low
First Quarter
$ 0.52
$ 0.023
Second Quarter
0.98
0.094
Third Quarter
0.45
0.181
Fourth Quarter
0.24
0.176
Holders
There
were 206 holders of record as of December 31, 2021; however, we believe the number of beneficial holders of our shares of common stock
to be approximately 290. In many instances, a registered stockholder is a broker or other entity holding shares in street name for one
or more customers who beneficially own the shares.
Dividends
We
have never paid cash dividends and have no plans to do so in the foreseeable future. Our future dividend policy will be determined by
our board of directors and will depend upon a number of factors, including our financial condition and performance, our cash needs and
expansion plans, income tax consequences, and the restrictions that applicable laws, any future preferred stock instruments, and any
future credit arrangements may then impose.
Issuer
Purchases of Equity Securities
None.
9
Securities
Authorized for Issuance under Equity Compensation Plans
The
Company does not have any equity compensation plans or any individual compensation arrangements with respect to its Common Stock or Preferred
Stock. The issuance of any of our Common Stock or Preferred Stock is within the discretion of our Board of Directors, which has the power
to issue any or all of our authorized but unissued shares without stockholder approval.
Recent
Sales of Unregistered Equity Securities
On
October 04, 2019, the Company issued 50,000,000 shares of common stock to Custodian Ventures, LLC at par for shares valued at $50,000
in exchange for settlement of a portion of a related party loan for amounts advanced to the Company in the amount of $20,100, and a note
receivable due to the Company in the amount of $29,900. The note bears an interest of 3% and matures in 180 days following written demand
by the holder. At December 31, 2020, the note receivable with a balance of $31,383 was written off because the collectability of the
note is unlikely after the change of control, the written off balance of the note consisted of the principal in the amount of $29,900
and interest receivable of $1,483.
On
May 4, 2020, the Company issued 5,000,000 shares of the Series A-1 Preferred stock valued at $5,000 to Custodian Ventures LLC as repayment
of funds loaned to the Company
All
of the securities set forth above were sold pursuant to exemptions from registration under Section 4(2) of the Securities Act of 1933,
as amended, as transactions by an issuer not involving any public offering. No general advertising or solicitation was used. And the
investors were purchasing the Shares for investment purposes only, without a view to resale. All issued securities were affixed with
appropriate legends restricting sales and transfers.
Item
6
Selected Financial Data.
This
item is inapplicable because we are a “smaller reporting company” as defined in Exchange Act Rule 12b-2.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.